Literature DB >> 22262034

Obesity and diabetes: an FGFR antibody with long-lasting effects.

Charlotte Harrison.   

Abstract

Entities:  

Year:  2012        PMID： 22262034     DOI： 10.1038/nrd3660

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1.

Authors:  Ai-Luen Wu; Ganesh Kolumam; Scott Stawicki; Yongmei Chen; Jun Li; Jose Zavala-Solorio; Khanhky Phamluong; Bo Feng; Li Li; Scot Marsters; Lance Kates; Nicholas van Bruggen; Maya Leabman; Anne Wong; David West; Howard Stern; Elizabeth Luis; Hok Seon Kim; Daniel Yansura; Andrew S Peterson; Ellen Filvaroff; Yan Wu; Junichiro Sonoda
Journal:  Sci Transl Med       Date:  2011-12-14       Impact factor: 17.956

Review 2.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.